Xtant Medical Holdings, Inc.XTNTNYSE
Loading
R&D Expenses Over TimeStrong
Percentile Rank73
3Y CAGR+33.3%
5Y CAGR+26.9%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+33.3%/yr
vs -14.4%/yr prior
5Y CAGR
+26.9%/yr
Recent acceleration
Acceleration
+47.6pp
Accelerating
Percentile
P73
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$2.17M-9.2%
2024$2.38M+78.5%
2023$1.34M+46.0%
2022$915000.00+5.2%
2021$870000.00+32.4%
2020$657000.00-29.5%
2019$932000.00-45.2%
2018$1.70M-30.3%
2017$2.44M-28.4%
2016$3.41M-